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Abstract 
Background:  Variations in genes related to the dopaminergic pathway have been 
implicated in neuropsychiatric disorders such as schizophrenia, substance misuse, 
Alzheimer’s disease and Post Traumatic Stress Disorder (PTSD).  A single nucleotide 
polymorphism (SNP) (957C>T) and a deletion polymorphism (-141delC) in the DRD2 
gene and a SNP (Taq1A) in a gene directly downstream of DRD2 have all been 
implicated in dopamine functioning in the brain.   
Methods:  To test the importance of these three polymorphisms in PTSD susceptibility, 
a genetic screen was performed in 127 war veterans diagnosed with PTSD and 228 
control individuals without a history of PTSD.   
Results:  No significant association was found between PTSD and the Taq1A or -
141delC polymorphisms.  However, a significant association was observed with PTSD 
and the 957C>T polymorphism.  PTSD individuals were more likely to carry the C 
allele compared to the controls (P = 0.021).   
Conclusions:  Our findings suggest that the 957C>T polymorphism in the DRD2 gene 
is one of the genetic factors for susceptibility to PTSD.   
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Introduction 
Post-traumatic stress disorder (PTSD) is a psychiatric condition that occurs following 
exposure to a life threatening experience.  PTSD has been reported to occur in about 8% 
of all Americans at some stage in their life with women twice as likely as men to 
develop the disorder (Kesssler 1995).  A common cause is stress after military combat 
but violent personal assaults, serious accidents and terrorist incidents can also lead to 
PTSD.  Individuals suffering from PTSD often relive the traumatic experience through 
flashbacks and nightmares, have difficulty sleeping, have problems with concentration 
and memory and are often easily startled or frightened.  PTSD is a highly debilitating 
condition with individuals frequently suffering poor relationships, self destructive 
behaviors, and hallucinations, feelings of isolation or hopelessness, and aberrant 
emotions ranging from numbness to anger.  While PTSD is considered an anxiety 
disorder it is often comorbid with major depression and has recently been shown to 
share a common genetic liability (Koenen et al.).  Biological symptoms are also seen 
with PTSD, including alterations in the central and autonomic nervous systems resulting 
in decreased processing and integration of memory (Kesssler 1995).  Hyper-arousal of 
the sympathetic nervous system is associated with PTSD and is characterized by sleep 
abnormalities.  Other biological characteristics of PTSD include increased thyroid 
function, lower cortisol but increased adrenaline and nor-adrenaline blood 
concentrations (Kesssler 1995).   
 
Familial and twin studies suggest that there is a genetic predisposition to PTSD.  For 
example, studies of twin males in military combat from the Vietnam war found that 
genetic factors significantly contribute to PTSD susceptibility (Koenen et al. 2002; True 
et al. 1993).  The risk of developing PTSD following combat trauma in Vietnam was 
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also found to be higher in individuals with a family history of depression (True et al. 
1993).  Similarly, in Cambodian refugees PTSD was found to cluster in families 
suggesting high heritability (Sack et al. 1995).   
 
The aetiology of PTSD has been associated with brain dopaminergic activity.  
Polymorphisms of the DRD2 (dopamine D2 receptor) gene (Klimek et al. 2002; 
Lawford et al. 2006; Schneier et al. 2000) which have been associated with differences 
in DRD2 density (Abi-Dargham et al. 2000; Seeman and Kapur 2000), reduced D2 
receptor binding (Noble et al. 1991; Thompson et al. 1997) and dopamine synthesis 
(Laakso et al. 2005) make DRD2 a good candidate for a significant genetic contribution 
to PTSD.  In addition, a synonymous polymorphism, 957C>T (rs6277) (Hanninen et al. 
2006; Hoenicka et al. 2006; Lawford et al. 2005) and a deletion polymorphism, 141del 
C (rs1799732) (Ohara et al. 1998) in the DRD2 gene have been found to be associated 
with schizophrenia, which shares some of the characteristics of PTSD and is also 
believed to result from dysregulation of dopamine.  Specifically, this mutation has been 
shown to affect mRNA stability and protein translation of the receptor (Duan et al. 
2003) and affects striatal dopamine D2 binding in healthy subjects (Hanninen et al. 
2006).  The T allele is associated with decreased DRD2 mRNA stability, decreased 
translation of DRD2 mRNA, and diminished dopamine induced up-regulation of D2 
receptors (Hirvonen et al. 2005). 
 
Another polymorphism situated in the DRD2 region known as TaqIA (rs1800497) is a 
non-synonymous G/A polymorphism found within the coding region of the ankyrin 
repeat and kinase domain containing 1 (ANKK1) gene which is located downstream of 
the DRD2 (Neville et al. 2004).  In a study of harmful drinkers, our group found that 
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those who were also diagnosed with PTSD were more likely to have the A1 (A) allele 
(Young et al. 2002). A similar association has also been shown with schizophrenia 
(Dubertret et al. 2004).  I A is a non-synonymous G/A polymorphism found within the 
coding region of the ankyrin repeat and kinase domain containing 1 (ANKK1) gene 
which is located downstream of the DRD2 (Neville et al. 2004).  The polymorphism is 
located in a putative substrate binding domain and results in a Glu713Lys substitution 
which has been suggested to alter substrate-binding specificity (Neville et al. 2004).  
The A1 (A) allele of the TaqIA polymorphism is associated with increased striatal 
activity of L-amino acid decarboxylase, the final enzyme involved in the biosynthesis of 
dopamine, thus possibly indicating increased dopamine synthesis (Laakso et al. 2005).  
 
As depression and anxiety disorders are associated with differences in receptor binding 
(Abi-Dargham et al. 2000; Klimek et al. 2002; Noble et al. 1991; Schneier et al. 2000; 
Seeman and Kapur 2000) and a genetic link exists between these disorders and PTSD, 
we postulate that -141del C and 957C>T polymorphisms in DRD2 and the TaqIA 
polymorphism in ANKK1 could be associated with increased PTSD susceptibility.   
 
Methods 
Patients and Participants 
One hundred and twenty seven unrelated male Caucasian patients diagnosed with PTSD 
using DSM IV criteria were recruited through the Greenslopes Private Hospital for the 
study.  All subjects were Vietnam combat veterans who had served in the Australian 
Armed Forces.  None were being treated with psychotropic medications.  Patients were 
excluded from the study if they had a diagnosis of psychosis, bipolar disorder, obsessive 
compulsive disorder, or organic brain syndrome including dementia.  All subjects had 
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sufficient comprehension of English and could understand the administered 
questionnaires. 
 
Patients were assessed for PTSD by a consultant psychiatrist or a senior psychiatric 
registrar using Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
criteria.  Furthermore, every patient exceeded the clinical cut-off score of 94 on the 
Mississippi Scale for combat-related PTSD (Keane et al. 1988).  Patient clinical history 
and demographic data including ethnic background were also obtained. 
 
After the procedure had been fully explained, all participants provided written informed 
consent.  They were able to terminate their involvement at any time during the interview 
without prejudice.  Institutional ethics approval was obtained from the Greenslopes 
Private Hospital. 
 
Two hundred and twenty eight unrelated Caucasian, representative of the general 
population were also collected as controls.   
 
Genotyping 
DNA was extracted from blood using standard techniques and subsequently used as a 
template for determination of DRD2 genotypes.  Genotyping for the 957C>T 
polymorphism was performed by kinetic real-time PCR using the Applied Biosystems 
7000 sequence detection system (Applied Biosystems, Foster City, CA, USA).  Allele 
specific forward primers were designed for the C allele (5′-
ATGGTCTCCACAGCACTCTC-3′), and the T allele (5′-
ATGGTCTCCACAGCACTCTT-3′) in addition to a common reverse primer (5′-
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CATTGGGCATGGTCTGGATC-3′).  A total of 5-10 ng of genomic DNA was 
amplified in 1 × SYBR green PCR master mix (Applied Biosystems) containing 0.4 μM 
of allele specific forward primer and 0.4 μM of common reverse primer in a 25 μL 
volume.  Amplification conditions were: 50°C for 2 min, 95°C for 10 min, followed by 
40 cycles of 95°C for 15s and 60°C for 1 min.  A cycle time (Ct) value was obtained by 
setting the threshold during geometric phase of amplification and scored relative to the 
ΔCt generated between the matched and mismatched primer pairs. 
 
TaqIA genotyping was performed by restriction fragment length polymorphism (RFLP) 
analysis of PCR products. A genomic sequence of 501 bp of the coding region of 
ANKK1 was amplified by PCR using the forward primer 5′-
GCACGTGCCACCATACCC-3′ and the reverse primer 5′-
TGCAGAGCAGTCAGGCTG -3′.  A total of 5-10 ng of genomic DNA was amplified 
in a PCR master mix containing 0.2 μM of forward primer and 0.2 μM of reverse 
primer, 1x PCR buffer, 1.5 mM MgCl2, 200 μM dNTPs and 1 unit of Platinum Taq 
DNA Polymerase (Invitrogen) in a 25 μL volume.  Amplification conditions were: Step 
1: 94°C for 4 min, Step 2: 94°C for 30 s, Step 3: 68°C for 30 s, Step 4: 72°C for 30 s, 
Steps 2-4 were repeated by 40 cycles followed by 72°C for 3 min.  Amplified PCR 
fragments were digested with TaqI restriction enzyme (New England Biolabs) and 
digested fragments were visualized via agarose gel electrophoresis. 
 
Determination of -141delC genotype was performed by RFLP analysis of PCR 
products.  A genomic sequence including 284 bp from the 5′-flanking region and 274 bp 
from exon 1 of DRD2 was amplified by PCR using forward primer 5′-
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ACTGGCGAGCAGACGGTGAGGACCC-3′ and reverse primer 5′-
TGCGCGCGTGAGGCTGCCGGTTCGG-3′.  A total of 5-10 ng of genomic DNA was 
amplified in a PCR master mix containing 0.2 μM of forward primer and 0.2 μM of 
reverse primer, 1x PCR buffer, 1.5 mM MgCl2, 200 μM dNTPs, 2x enhancer solution 
(Invitrogen) and 1 unit of Platinum Taq DNA Polymerase (Invitrogen) in a 25 μl 
volume.  Amplification conditions were: Step 1: 95°C for 3 min, Step 2: 95°C for 30 s, 
Step 3: 68°C for 30 s, Step 4: 72°C for 30 s, Steps 2-4 were repeated 40 times followed 
by a final 72°C step for 2 min.  Amplified PCR fragments were digested with BstNI 
restriction enzyme (New England Biolabs) and digested fragments were visualized via 
agarose gel electrophoresis. 
 
Statistical Analysis 
For each polymorphism, a homogeneity χ2 analysis was employed to test the hypothesis 
of homogeneity of allele frequency distributions between PTSD and control 
populations. An odds ratio with 95% confidence interval (CI) was also calculated. 
Genotype frequencies were similarly compared between PTSD and control populations. 
However, where an allele was found to be associated with PTSD, an extended Mantel-
Haenszel test was performed to test for a trend to PTSD with increasing copy number 
(0, 1, or 2) of the allele. Odds ratios were calculated relative to the homozygote for the 
non-associated allele and population attributable fractions calculated.  The calculations 
for attributable risk were done using genotypes counting the presence of the C allele as 
a risk factor.  All statistics were carried out using the epidemiological software 
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Three polymorphisms in the DRD2 region were genotyped and investigated for an 
association with PTSD.  The 957C>T polymorphism showed a significant association 
with PTSD at the allele level (P = 0.021, Table 1).  The C allele was found at a higher 
frequency in the PTSD patients (51.7%) compared to the controls (42.5%).  The odds 
ratio (OR) of having PTSD when an individual has the C allele was 1.45 (confidence 
interval 1.04-2.01).  The genotypes of both groups are displayed in Table 2.  A 
significant trend in susceptibility to PTSD was found with respect to increasing C 
alleles in genotypes (P = 0.021).  The odds of an individual with PTSD having the CC 
genotype (rather than the TT genotype) are twice that of the controls (P = 0.041).  Using 
Compare2 v1.25 software, attributable fraction was calculated using genotypes counting 
the presence of the C allele as a risk factor.  The attributable fraction, which is the 
proportion of cases in the study population that would not have occurred had the risk 
factor (risk allele) not been present, is a useful measure to quantify the impact of the 
allele on the development of PTSD (Lappalainen et al. 2002).  The analysis revealed 
14% of the susceptibility to PTSD could be attributed to having the CC genotype of the 
957C>T DRD2 polymorphism.   
No association with PTSD was observed for the TaqIA or -141delC polymorphisms at 
the allele (Table 1) or genotype level (Table 2).  Both PTSD and control groups were 
determined to be in Hardy-Weinberg equilibrium based on the respective allele 
frequencies of each group.   
 
Discussion 
This is the first study reporting an association with the DRD2 957C>T polymorphism 
and PTSD.  The C allele of the DRD2 957C>T polymorphism was found to be 
significantly associated with the disorder.  PTSD individuals were more likely to carry 
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the C allele compared to healthy controls.  Fourteen percent of the susceptibility to 
PTSD could be attributed to having the CC genotype of the DRD2 polymorphism.  Our 
results suggest that the 957C>T polymorphism contributes to the genetic susceptibility 
to PTSD.   
 
Earlier studies have found that dopaminergic innervation of the prefrontal cortex is 
highly sensitive to both acute and chronic stress (Deutch and Roth 1990).  Our results 
support the hypothesis that a defect in the central dopaminergic pathway contributes to 
post-traumatic symptomatology (Deutch AY 1995).  A polymorphism in the DRD2 
receptor which is central to the dopamine system could result in increased production of 
dopamine thus increasing the risk of psychopathology consequent to traumatic 
exposure.   
 
Our data fail to support an allelic or genotypic association between the TaqIA 
polymorphism of the ANKK1 gene and PTSD.  These results do not follow the findings 
by Comings et al. (Comings et al. 1996) that the A1 allele is associated with PTSD.  Of 
37 Vietnam veterans from an addiction treatment unit who had been diagnosed with 
PTSD, 22 (59.5%) carried the A1 allele.  This compared with only 1 of 19 (5.3%) 
carrying the A1 allele among individuals who did not have PTSD (Comings et al. 
1996).  Our results are, however, similar to those of Gelernter et al. (Gelernter et al. 
1999) who also found no association between TaqIA and PTSD.  A possible 
explanation for this is the nature of the control population used by Comings et al.  While 
Gelernter et al. and our group used random control populations, Comings et al. used 
Vietnam veterans who had not developed PTSD.  Interestingly, our group has 
previously demonstrated an association between the A1 allele and PTSD (P = 0.004) 
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but also showed that this was almost entirely as a consequence of a very significant 
association of A1 with a subgroup of PTSD patients designated as “harmful drinkers” 
(P = 0.00017).  Both PTSD populations studied by Gelernter et al. and Comings et al. 
were similar in that all or almost all were comorbidly drug or alcohol dependent.   
 
In non-clinical subjects, a significant relationship has been reported between dopamine 
D2 receptor binding and depression (Kestler et al. 2000).  Also, subjects with 
schizophrenia treated with typical antipsychotic drugs show a worsening of depressive 
symptoms with increasing dopamine D2 receptor occupancy (Bressan et al. 2002).  
Similarly, it has been shown that in patients with schizophrenia treated with the atypical 
antipsychotics, olanzapine or risperidone, high dopamine D2 receptor occupancy was 
related to the subjective experience of depression (de Haan et al. 2000).  Future studies 
should further investigate the C957C>T as a risk for PTSD with comorbid depression.   
 
The current study recruited male war veterans only and the results may not be 
generalized to females or individuals who were exposed to trauma other than combat 
(for example, trauma related to sexual abuse).  Stein et al. (2000) (Stein et al. 2000) 
identified gender differences in susceptibility to PTSD.  Women were found to be at a 
significantly increased risk for PTSD following exposure to serious trauma.  A recent 
study also observed gender differences in the sensitivity to PTSD (Breslau and Anthony 
2007).  Results found that the relative risk estimate for a second traumatic event was 
significantly higher in woman compared to men.  The age range of patients was also 
restricted and there was a period of several decades between traumatic exposure and 
recruitment for this research.  This study does not rule out population stratification and 
therefore our result needs be confirmed by independent replication in a Caucasian group 
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as well as defined ethnic groups.  The sample size for the PTSD population in our study 
was small and the association will need to be confirmed independently, preferably using 
a larger sample size of PTSD patients.  However, a P-value of 0.021 is encouraging 
using unselected controls as a more significant association is likely to be found using 
controls screened for lack of exposure to a traumatic event.  In this study we used a 
control population drawn from a normal population who had possibly been exposed to a 
traumatic event.  Using a general population as controls we were able to calculate 
attributable risk and conclude that 14% of the susceptibility to PTSD could be attributed 
to having the CC genotype.  We did not adjust our p-values for multiple testing as the 
validity of this technique is controversial (Perneger 1998).  Therefore our significant 
association must be seen as exploratory and further replication is required.  Further 
studies should also employ a control group which is characterised by combat exposure 
but who do not have PTSD (Bachmann et al. 2005).   
 
In conclusion, considerable evidence emphasizes the importance of dopamine D2 
receptor function in both anxiety and depression.  This study supports these findings, by 
reporting for the first time that the 957C allele of the DRD2 gene is associated with 
PTSD in Vietnam War veterans.  These findings suggest that genetic variation in the 
dopaminergic pathway may play an important role in the response to stress in humans.  
Further investigation of the 957C>T DRD2 polymorphism in anxiety and depression 
may improve understanding of the pathophysiology of these disorders and may 
eventually lead to targeted pharmacogenomic treatment strategies. 
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TABLE 1.  Allele frequencies of 957C>T, TaqI A and –141delC polymorphisms of 
the DRD2 region in patients with post traumatic stress disorder (PTSD) compared 
to controls. 
 
Group n Allele frequency χ2  P  Odd's Ratio 
(95% CIa) 
957C>T  C (%) T (%)    
Control 452 192 (42.5) 260 (57.5) 
5.34 0.021 
1.45            
(1.04 – 2.01) PTSD 240 124 (51.7) 116 (48.3) 
TaqI A  A1 (%) A2 (%)    
Control 446 77 (17.3) 369 (82.7) 
2.80 0.094 
1.39           
(0.93 – 2.07) PTSD 254 57 (22.4) 197 (77.6) 
–141delC  Del (%) Ins (%)    
Control 424 48 (11.3) 376 (88.7) 
0.71 0.40 
0.78            
(0.42 – 1.42) PTSD 198 18 (9.1) 180 (90.9) 
a Fisher’s  exact confidence interval. 
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TABLE 2.  Genotype frequencies of 957C>T, TaqI A and –141delC polymorphisms 
of the DRD2 region in patients with post traumatic stress disorder (PTSD) 
compared to controls. 
 
Group n Genotype frequency χ2         (P) 
957C>T  C/C (%) C/T (%) T/T (%)  
Control 226 40 (17.7) 112 (49.6) 74 (32.7) 5.37 * (0.068) 
5.33 a (0.021) PTSD 120 32 (26.7) 60 (50.0) 28 (23.3) 
Odds Ratiob  2.114 
P = 0.041 
1.493 
P = 0.324 
1.000 
 
Attributable Fractionc ±SE  14.05 ± 5.71% 
P = 0.007 
14.68 ± 10.64% 
P = 0.084 
 
 
TaqI A  A1/A1 (%) A1/A2 (%) A2/A2 (%)  
Control 223 8 (3.5) 61 (27.4) 154 (69.1) 3.67 * (0.160) 
2.79 a  (0.095) PTSD 127 5 (3.9) 47 (37) 75 (59.1) 
–141delC  Del/Del (%) Del/Ins (%) Ins/Ins (%)  
Control 212 4 (1.9) 40 (18.9) 168 (79.2) 
0.74 (0.691)  d 
PTSD 99 1 (1) 16 (16.2) 82 (82.8) 
* Likelihood-ratio χ2 test . 
aMantel-Haenszel χ2 test for trend. 
 b With respect to homozygous genotype of allele not associated with schizophrenia 
c The proportion of PTSD rate that can be attributed to having 1 or 2 copies of the susceptibility allele.  Assumes genotype 
frequencies in controls are representative of the population and that the odds ratio is an accurate estimate of risk. 
d Likelihood-ratio χ2 test .At least one cell has an expected frequency of < 5 
 
